PAR 3.77% 25.5¢ paradigm biopharmaceuticals limited..

research reports and media, page-709

  1. 822 Posts.
    lightbulb Created with Sketch. 328
    Most trading platforms provide PE ratio’s for individual stocks and there can be a wide dispersion between stocks in a similar category I.e Bio Tech.
    You would expect PAR’s PE to be higher than CSL’s because it will have a higher growth component as it is coming from a lower earnings base, has a lot more unknowns and market expectation is high. This does not mean the PE is justifiable, but it shows the froth in the stock.
    CSL’s PE on 06/20’s estimated earning and current price is 43.9
    CBA’s PE on 06/20’s estimate is 16.9
    The banking sector’s average PE is 17.08
    The Bio Tech sectors average PE IS 43.89

    So in general Bio’s trade at a much higher PE on average than banks... Why ... because Bio’s have much more potential to out perform than banks.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
25.5¢
Change
-0.010(3.77%)
Mkt cap ! $89.19M
Open High Low Value Volume
27.0¢ 27.0¢ 25.5¢ $162.7K 620.9K

Buyers (Bids)

No. Vol. Price($)
2 25008 25.5¢
 

Sellers (Offers)

Price($) Vol. No.
26.0¢ 34768 1
View Market Depth
Last trade - 16.10pm 26/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.